Arvinas holder plans sale of 30,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
A shareholder of Arvinas (ARVN), Noah C. Berkowitz, filed notice of a proposed sale of 30,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services at New York Plaza. The filing lists an approximate aggregate sale price of $264,000.
The disclosure also reports that 24,000 shares of common stock were sold on 07/09/2026 for $201,528. In addition, restricted stock is scheduled to vest under a registered plan in two tranches: 18,692 shares on 05/09/2026 and 11,308 shares on 07/03/2026, each noted as compensation for services rendered.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Vesting Under a Registered Plan financial
Services Rendered financial
Securities Sold During The Past 3 Months regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock sale is disclosed for Arvinas (ARVN) in this Form 144?
What Arvinas (ARVN) stock has already been sold in the past three months?
Who is the selling security holder in the Arvinas (ARVN) Form 144?
Which broker is handling the proposed Arvinas (ARVN) stock sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.